Your browser doesn't support javascript.
loading
SAF-248, a novel PI3Kδ-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma.
Zhang, Xi; Duan, Yu-Ting; Wang, Yi; Zhao, Xing-Dong; Sun, Yi-Ming; Lin, Dong-Ze; Chen, Yi; Wang, Yu-Xiang; Zhou, Zu-Wen; Liu, Yan-Xin; Jiang, Li-Hua; Geng, Mei-Yu; Ding, Jian; Meng, Ling-Hua.
Afiliación
  • Zhang X; Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Duan YT; Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Wang Y; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Zhao XD; Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Sun YM; Fochon Pharmaceuticals, Ltd., Chongqing, 404100, China.
  • Lin DZ; Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Chen Y; Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Wang YX; Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Zhou ZW; University of Chinese Academy of Sciences, Beijing, 100049, China.
  • Liu YX; Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China.
  • Jiang LH; Fochon Pharmaceuticals, Ltd., Chongqing, 404100, China.
  • Geng MY; Fochon Pharmaceuticals, Ltd., Chongqing, 404100, China.
  • Ding J; Fochon Pharmaceuticals, Ltd., Chongqing, 404100, China.
  • Meng LH; University of Chinese Academy of Sciences, Beijing, 100049, China. mygeng@simm.ac.cn.
Acta Pharmacol Sin ; 43(1): 209-219, 2022 Jan.
Article en En | MEDLINE | ID: mdl-33782541

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Fosfatidilinositol 3-Quinasa Clase I / Inhibidores de las Quinasa Fosfoinosítidos-3 / Antineoplásicos Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Fosfatidilinositol 3-Quinasa Clase I / Inhibidores de las Quinasa Fosfoinosítidos-3 / Antineoplásicos Idioma: En Revista: Acta Pharmacol Sin Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article